Procter & Gamble vs. Clorox: Evaluating Consumer Staples for 2026

As investors look toward 2026, the choice between Procter & Gamble (PG) and The Clorox Company (CLX) highlights a classic trade-off between massive global scale and specialized market focus. Procter & Gamble remains a diversified powerhouse, leveraging a vast portfolio across ten categories and 180 countries to maintain a robust 19% net margin. Conversely, Clorox offers a more concentrated approach, focusing on household cleaning and wellness brands, though it operates with a significantly smaller financial footprint and a more leveraged balance sheet.

Financial performance for both companies in fiscal 2025 shows a trend of modest, stable growth, with revenue increases hovering near flat for both entities. However, the divergence in their capital structures is notable. Procter & Gamble maintains a more conservative debt-to-equity ratio of 0.7x, reflecting a stronger ability to manage its financial obligations. Clorox, while profitable, carries a much higher debt-to-equity ratio of 9.0x, which may present higher risk for investors sensitive to interest rate fluctuations or capital-intensive operations.

Both companies share a significant vulnerability: high customer concentration. With Walmart accounting for 16% of Procter & Gamble’s sales and a substantial 27% of Clorox’s revenue, both firms are susceptible to shifts in retail strategy or pricing negotiations. Ultimately, the decision for investors hinges on their risk appetite; Procter & Gamble offers the stability of a global conglomerate, while Clorox provides a targeted, albeit more leveraged, play in the consumer staples sector.